{"transactions":[{"id":1042704,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-09-11T22:14:37.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant."}],"balance_after":17600,"derivative":{"exercise_price":3.61,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001411685-25-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141168525000074/edgardoc.xml","form_type":"4"}},{"id":1410711,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-10T21:00:10.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":14100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (\"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance (\"Grant Date\"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date."}],"balance_after":14100,"derivative":{"exercise_price":3.25,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":14100},"source":{"system":"sec-edgar","filing":"0001415889-24-023146","document":"form4-09102024_050905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924023146/form4-09102024_050905.xml","form_type":"4"}},{"id":1591377,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T23:00:10.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant."}],"balance_after":12500,"derivative":{"exercise_price":4.85,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-007095","document":"form4-03062024_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924007095/form4-03062024_060304.xml","form_type":"4"}},{"id":2353755,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:15:33.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan.  Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":1.37,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-22-002296","document":"form4-03032022_010313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588922002296/form4-03032022_010313.xml","form_type":"4"}},{"id":2729872,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:39:28.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest on the one-year anniversary of the grant date, with the remaining 75% vesting ratably on a monthly basis over the 36 months thereafter. Stock options were granted in connection with the Reporting Person's appointment to the Issuer's Board of Directors and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan."}],"balance_after":300000,"derivative":{"exercise_price":2.53,"expiration_date":"2031-05-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-21-002243","document":"form4-05042021_010553.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921002243/form4-05042021_010553.xml","form_type":"4"}},{"id":2925400,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T21:59:53.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":75000,"derivative":{"exercise_price":1.77,"expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-21-000022","document":"form4-01042021_010143.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000022/form4-01042021_010143.xml","form_type":"4"}},{"id":3169001,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T21:10:32.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the \"Vesting Start Date\") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date."}],"balance_after":75000,"derivative":{"exercise_price":0.398,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-20-001063","document":"form4-04272020_050419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588920001063/form4-04272020_050419.xml","form_type":"4"}},{"id":3389703,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-22T21:01:09.000Z","date":"2019-10-21","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter."}],"balance_after":75000,"derivative":{"exercise_price":1.41,"expiration_date":"2029-10-21","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-19-001210","document":"form4-10222019_051043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919001210/form4-10222019_051043.xml","form_type":"4"}},{"id":3510180,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T20:16:02.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the Shares subject to the Option reported herein shall vest on Vesting Start Date May 23, 2019, and 1/36th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter."}],"balance_after":50000,"derivative":{"exercise_price":1,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-19-000591","document":"form4-05282019_010549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919000591/form4-05282019_010549.xml","form_type":"4"}},{"id":3696332,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":50893,"kind":"person","name":"Cunningham Ann Michelle","position":1,"cik":"0001764572","reported_name":"Cunningham Ann Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-15T02:55:16.000Z","date":"2019-01-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option reported herein will vest ratably, on a monthly basis, beginning on the date of issuance until March 31, 2019."}],"balance_after":25000,"derivative":{"exercise_price":1.74,"expiration_date":"2029-01-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-19-000051","document":"form4-01142019_090102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588919000051/form4-01142019_090102.xml","form_type":"4"}}]}